First Time Loading...

Alimera Sciences Inc
NASDAQ:ALIM

Watchlist Manager
Alimera Sciences Inc Logo
Alimera Sciences Inc
NASDAQ:ALIM
Watchlist
Price: 3.36 USD 2.44% Market Closed
Updated: May 15, 2024
Section:
 

Wall Street
Price Targets

ALIM Price Targets Summary
Alimera Sciences Inc

Wall Street analysts forecast ALIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALIM is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

ALIM Lowest Forecast
Wall Street Target
6.06 USD
80% Upside
ALIM Average Forecast
Wall Street Target
8.16 USD
143% Upside
ALIM Highest Forecast
Wall Street Target
10.5 USD
213% Upside
Lowest
Price Target
6.06 USD
80% Upside
Average
Price Target
8.16 USD
143% Upside
Highest
Price Target
10.5 USD
213% Upside
Alimera Sciences Inc Competitors:
Price Targets
SUVENPHAR
Suven Pharmaceuticals Ltd
26% Upside
K
KOTRA
Kotra Industries Bhd
19% Upside
600195
China Animal Husbandry Industry Co Ltd
34% Upside
603590
Beijing Konruns Pharmaceutical Co Ltd
47% Upside
SUVENPHAR
Suven Pharmaceuticals Ltd
26% Upside
K
KOTRA
Kotra Industries Bhd
19% Upside
600195
China Animal Husbandry Industry Co Ltd
34% Upside
603590
Beijing Konruns Pharmaceutical Co Ltd
47% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
2% Downside
D
170900
Dong-A ST Co Ltd
35% Upside
603229
Zhejiang Ausun Pharmaceutical Co Ltd
78% Upside
CTLT
Catalent Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Alimera Sciences Inc

For the last 8 years the compound annual growth rate for Alimera Sciences Inc's revenue is 17%. The projected CAGR for the next 3 years is 20%.

17%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Alimera Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Alimera Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
What are analyst estimates?

See Also

Summary
ALIM intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALIM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALIM stock valuation using valuation multiples.
Wall Street Estimates
ALIM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALIM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ALIM's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for ALIM is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

What is Alimera Sciences Inc's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Alimera Sciences Inc's revenue is 17%. The projected CAGR for the next 3 years is 20%.

ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.